It is important to distinguish between malignant and benign tissue to ensure that BC patients receive timely and appropriate treatment. Misclassification can lead to unnecessary procedures and delays in intervention, which can have a negative impact on the patient's health. As a result, CAD systems must be accurate and reliable to improve diagnostic accuracy in clinical practice. Therefore, we discuss the specific mechanisms used to distinguish malignant from benign tissue in the proposed CAD system, as well as the underlying formulations and evaluation criteria.
Tumor-centered coloring framework simultaneously improves clinical interpretability by highlighting visually suspicious areas, thereby increasing radiologists more rapidly diagnostic reliability, i.e., confidence in the diagnosis, simultaneously improving clinical interpretability, especially when traditional gray images can obscure subtle abnormalities. This visual augmentation streamlines the diagnostic process by reducing interpretation time and fostering rapid decision-making without imposing additional cognitive loads, as integrated color schemes eliminate the need for separate post-processing steps that are often associated with traditional CAD systems. As a result, this approach represents a clinically validated solution that supports efficient breast cancer screening in a high-throughput clinical setting, contributing to faster patient evaluation, minimizing diagnostic delays, improving workflow efficiency, and ultimately earlier detection and better patient outcomes.
Fundamentals for grayscale color transformation in tissue differentiation.
Colored mammograms offer a significant enhancement of tissue differentiation capabilities when converted from grayscale to color. Accurate diagnosis based on traditional grayscale mammograms is difficult due to non-co-treatment of natural contrast, background noise, and regional contrast. This method overcomes these constraints by processing the mammographic image in three separate channels and generating color-enhancing representations that enhance microtissue properties that may otherwise be irrelevant. Targeted channel-specific improvements allow differentiation between benign and malignant tissue due to different morphological and texture properties. Combining these improved channels with color representations allows images with high variation between healthy, benign and malignant tissues. This improved visualization allows for more accurate extraction and classification of features. Mathematically, compound reinforcement is expressed by equations. 11.
$$\begin{aligned} x_\textrm{color}(x,y)=[E_\textrm{R}(X_\textrm{Orig}(x,y)),E_\textrm{G}(X_\textrm{Orig}(x,y)),E_\textrm{B}(X_\textrm{Orig}(x,y))] \end {aligned} $$
(11)
where \(x_ \textrm {color}(x,y)\), \(x_ \textrm {orig}(x,y)\), \(e_ \textrm {r} \), \(e_ \textrm {g} \)and \(e_ \textrm {b} \) Represents the final color image, the original grayscale mammogram, and the extended operations for the red, green and blue channels, respectively.
Mammogram feature extraction from color-enhanced images
Following color enhancements, a pre-trained CNN is implemented. It uses models such as ResNet, VGG, EfficientNet, etc to extract functionality from images without updating model weights. Next, separate ML models such as SVM are used to classify the extracted features. Layers in CNN models process images step by step. Each focuses on different aspects of the image, capturing different organizational properties that trigger layer-specific activation, a system of learning representation that captures patterns beyond the scope of traditional feature engineering, and layer-specific activation maps such as early layers to accommodate edges and deep layers.
Identification of benign and malignant tissues based on their properties
The proposed method of increasing colour highlights several important properties that distinguish benign from malignant breast tissue. First, malignant masses are usually characterized by irregular (spinned) or unclear boundaries, whereas benign masses are usually characterized by smooth, well-enclosed boundaries. This boundary variation is highlighted by the proposed channel-specific improvement. Second, benign lesions usually exhibit uniform patterns, whereas malignant lesions may exhibit varying internal compositions and irregular density distributions. The variation in these compositions is apparent as a result of color changes. Third, improved images tend to emphasize architectural distortions in surrounding organizations. This is often caused by malignant tissues. Finally, malignant masses usually have irregular shapes, in contrast to benign masses that are more regular, oval or circular.
Diagnostic colours of tumor centers for enhanced lesion detection in high density breast tissue: a multi-channel framework for radiographic and CNN-based interpretation
Density breast tissue presents an important diagnostic challenge due to its high masking effect, reduced sensitivity, or speed of false negatives, as malignant lesions and fibroblast structures appear radio-permeable. This study introduces a tumor-centered pigmentation framework to improve lesion detection across different breast densities, representing a paradigm shift from traditional grayscale analysis. In the proposed method, the intensity of the tumor signal is enhanced using histogram-based intensity enhancement within the 108-130 range and color channel mapping used for noise suppression, lesion removal, and adaptive normalization across the RGB channels. In doing so, the grayscale mammogram is transformed into visually and computationally enriched representations optimized for CNNS-based feature extraction and clinical interpretation.
In addition to improving computational separation, diagnostic dyeing provides radiologists with three synergistic mechanisms to address challenges related to dense tissue. First, it promotes reverse contrast of the lesions and counters the masking effects of dense breast imaging. This allows you to detect subtle architectural distortions and irregular masses that hide traditional grayscale images. Furthermore, this methodology enriches the feature space of AI systems via complementary RGB channels, each optimized for a specific diagnostic task. This allows convolutional neural networks to extract morphological patterns that cannot be detected by single-channel grayscale analysis. Additionally, it promotes rapid clinical decision-making by providing diagnostically relevant “hot spots”, intuitive color-coded indicators that guide the attention of radiologists in suspicious areas.
The Mini-DDSM dataset contains a wide range of breast densities despite the lack of formal density annotations. Qualitative assessments ensure that the system is accurately identifying the lesions classified in dense cases, as reflected in published performance metrics. This method appears to be likely to effectively generalize to different types of breast tissue composition based on this preliminary evidence. In the future, we will focus on density-based verification and comparing reinforcement technologies specific to high-density tissues.
Functional extraction using pre-trained models: mathematical representations
The mathematical feature extraction process involves converting raw images into high-dimensional feature vectors through convolution, activation, and pooling operations. Assume \(\ phi cnn \) A pre-trained CNN with weight initialized with Imagenet. Mammograms are used to fine-tune the model to fit the pattern of medical imaging. The convolutional layer, activation function, and pooling layer are important layers of feature extraction. Hierarchical spatial patterns such as edges, textures, and shapes are extracted by convolutional layers. The activation function introduces nonlinearity, e.g., rectifying linear units (Relu), when the pooling layer reduces spatial dimensions. Use mammogram images \({\textbf {x}}\in\mathbb {r}^\mathrm {h\times w \times 3}\) This will be a color-transformed mammogram. 12. Analyze images with CNNS processing \({\ textbf {x}} \) Through l Layer location h and w They represent height and width, respectively.
$$\begin{aligned} {\textbf {f}}^\textrm {l} = \sigma({\textbf {w}}^\textrm {l}\circledast {\textbf {x}}}^\matrm {l-1-ut {b}}^\textrm {l})\end {aligned} $$
(12)
Layer feature map la learnable convolution filter, and bias terms are \({\textbf {f}}^\textrm {l} \), \({\textbf {w}}^\textrm {l} \)and \({\textbf {b}}^\textrm {l} \)respectively. \(\sigma(\cdot)\) Nonlinear activation function, e.g. relu \(\ circledaster \) Represents a convolution operation. That's what you need to be careful about \({\textbf {w}}^\textrm {l} \) and \({\textbf {b}}^\textrm {l} \) It is not updated as it uses a pre-trained model.
Equation 13 shows the maximum/average pooled feature map of the layer lwhere \(\text {pool} {(\cdot)} \) and s It has a pooling function (maximum pooling, average pooling) and stride size, respectively.
$$\begin{aligned}{\textbf{f}}_\textrm{pooled}^\textrm{l} =\text{pool}({\textbf{f}}^\\textrm{l},s
(13)
Equation 14, the final feature map is flattened into feature vectors after several convolutional and pooling layers.
$$\begin{aligned}{\textbf{f}}=\phi(w_\textrm{fc}\cdot\text{flatten}(f^\mathrm{(l)})+b_\textrm{fc})
(14)
meanwhile \({\textbf {f}}\in\mathbb {r}^\mathrm {h\times w \times 3}\), l, \(w_ \textrm {fc} \)and \(\phi(\cdot)\) Represents the extracted feature vector, the final convolutional layer, the weights of the fully connected layers (if any), and the activation function, respectively.
Classification
Individual classifiers like SVM are adopted to classify extracted feature vectors f Because the CNN classification head has been removed as shown in the equation. 15.
$$\begin{aligned} y=\text{svm}({\textbf{f}})\end{aligned} $$
(15)
where y The predicted classification of tumors is classification as benign or malignant.
Color enhancement and interpretability
By mapping diagnostically relevant features to distinct color channels, the proposed dyeing technique increases the visibility of subtle anomalies in radiologists and supports AI detection models. In the case of radiologists, improved perceptions of malignant and benign tissue reduce interpretive ambiguity and allow for more confident and timely clinical decisions. This is especially important in dense or complex cases where grayscale images can obscure important findings.
Coloring improves visibility and makes it easier to distinguish suspicious features such as trace calcifi and irregular masses from surrounding tissue. This leads to more effective identification of subtle lesions that may be overlooked in grayscale images. Recent studies have shown that color-enhanced mammograms result in higher agreement among observers, reducing diagnostic ambiguity, leading to more consistent and timely diagnostic interpretations. Ultimately, this contributes to early breast cancer detection, improved clinical certainty, and improved patient outcomes.
On a technical level, pigmentation enhances the input data of deep learning algorithms by extending feature spaces and highlighting tumor-related patterns that are difficult to distinguish from grayscale images. Color-enhanced input data allows AI systems to learn more differential features, resulting in less erroneous errors and fewer false positives to improve classification accuracy. Additionally, the colour framework improves clinician interpretability while improving overall performance and reliability.
